Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2000063223) NOVEL 8A- AND 9A-15-MEMBERED LACTAMS
Latest bibliographic data on file with the International Bureau   
Pub. No.: WO/2000/063223 International Application No.: PCT/HR2000/000009
Publication Date: 26.10.2000 International Filing Date: 19.04.2000
Chapter 2 Demand Filed: 16.11.2000
IPC:
C07H 17/08 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
H
SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
04
Heterocyclic radicals containing only oxygen as ring hetero atoms
08
Hetero rings containing eight or more ring members, e.g. erythromycins
Applicants:
LAZAREVSKI, Gorjana [HR/HR]; HR (UsOnly)
ALIHODŽIĆ, Sulejman [HR/HR]; HR (UsOnly)
KOBREHEL, Gabrijela [HR/HR]; HR (UsOnly)
MUTAK, Stjepan [HR/HR]; HR (UsOnly)
PLIVA, FARMACEUTSKA INDUSTRIJA, DIONICKO DRUSTVO [HR/HR]; Ulica grada Vukovara 49 10000 Zagreb, HR (AllExceptUS)
Inventors:
LAZAREVSKI, Gorjana; HR
ALIHODŽIĆ, Sulejman; HR
KOBREHEL, Gabrijela; HR
MUTAK, Stjepan; HR
Agent:
PLIVA D.D. PRAVNI POSLOVI; Vesna Vasiljevic Ulica grada Vukovara 49 10000 Zagreb, HR
Priority Data:
P990116A20.04.1999HR
Title (EN) NOVEL 8A- AND 9A-15-MEMBERED LACTAMS
(FR) NOUVEAUX LACTAMES 8A ET 9A A 15 ELEMENTS
Abstract:
(EN) The invention relates to novel 15-membered 8a- and 9a-lactams from the class of 6-$i(O)-methyl-erythromycin A of general formula (I), their pharmaceutically acceptable addition salts with inorganic or organic acids and their hydrates, wherein A stands for NH group and B simultaneously stands for C=O group, or A stands for C=O group and B simultaneously stands for NH group, and the radicals R1, R2, R3, R4, R5, R6 have the meaning given in claim 1.
(FR) La présente invention concerne de nouveaux lactames 8a et 9a à 15 éléments issus de la classe du composé 6-$i(O)-méthyl-érythromycine A de formule (I), leurs sels d'addition pharmaceutiquement acceptables avec des acides organiques ou inorganiques et leurs hydrates. Dans la formule (I), A représente un groupe NH et B représente simultanément un groupe C=O, ou A représente un groupe C=O et B représente simultanément un groupe NH ; les radicaux R1, R2, R3, R4, R5 et R6 correspondent à la signification donnée dans la revendication 1.
 front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)